Characteristics of the study group (median and range)
| . | Controls (Control) . | CLL . | CML . | ALL . | AML . | MDS . |
|---|---|---|---|---|---|---|
| No. blood vessels | 11.2 (1.2-24) | 9 (1.3-36.7) | 21.4 (4.7-41.7) | 18 (5.2-45.2) | 16.1 (1.2-32.8) | 20.4 (2.7-41.6) |
| Area (%) | 2.8 (.17-8.7) | 2.4 (.12-11.2) | 6.2 (.9-13.1) | 4.4 (.5-15.4) | 4.3 (.34-23.1) | 5.2 (.4-13.1) |
| PB Hb (g/dL) | 12.9 (9.2-16.8) | 12.8 (6.8-16) | 12.1 (10.1-15.1) | 10.9 (6.1-12.2) | 10.2 (7.1-14.7) | 9.7 (7.2-14.2) |
| PB WBC (×109/L) | 5.4 (1.8-13.1) | 17.3 (3.4-249.9) | 22.8 (2.4-307.4) | 13 (.4-79.8) | 7.9 (.8-124) | 6.6 (.7-64.9) |
| PB Plts | 171 (20-527) | 118 (21-232) | 252 (39-1430) | 36 (5-230) | 41.4 (11-203) | 44.5 (1-413) |
| PB Nt (% of WBC) | 62 (24-76) | 18 (0-73) | 58 (20-85) | 8 (0-89) | 6 (0-76) | 34.5 (3.74) |
| PB Ly (% of WBC) | 21 (14-72) | 71 (10-97) | 10.5 (1.36) | 12 (0-66) | 28 (2-93) | 30.5 (2-90) |
| BM cellularity (%) | 20 (10-50) | 50 (15-95) | 90 (20-100) | 85 (10-95) | 80 (15-100) | 63 (15-100) |
| BM blasts (%) | 1 (0-4) | 0 (0-0) | 2 (0-47) | 92 (79-99) | 70 (1-99) | 8.5 (2-29) |
| BM progranulocytes (%) | 2 (1-4) | 0 (0-2) | 2 (0-12) | 0 (0-4) | 1 (0-90) | 2 (0-10) |
| BM granulocytes (%) | 19 (12-31) | 5 (0-22) | 23 (10-63) | 0 (0-7) | 1.5 (0-29) | 14.5 (0-41) |
| BM Ly (%) | 13 (4-26) | 76 (7-93) | 4 (0-14) | 1 (0-7) | 5.5 (0-51) | 8 (2.57) |
| BM basophils (%) | 0 (0-2) | 0 (0-1) | 1 (0-11) | 0 (0-0) | 0 (0-1) | 0 (0-7) |
| BM prolymph (%) | 0 (0-0) | 1 (0-48) | 0 (0-0) | 0 (0-0) | 0 (0-0) | 0 (0-0) |
| . | Controls (Control) . | CLL . | CML . | ALL . | AML . | MDS . |
|---|---|---|---|---|---|---|
| No. blood vessels | 11.2 (1.2-24) | 9 (1.3-36.7) | 21.4 (4.7-41.7) | 18 (5.2-45.2) | 16.1 (1.2-32.8) | 20.4 (2.7-41.6) |
| Area (%) | 2.8 (.17-8.7) | 2.4 (.12-11.2) | 6.2 (.9-13.1) | 4.4 (.5-15.4) | 4.3 (.34-23.1) | 5.2 (.4-13.1) |
| PB Hb (g/dL) | 12.9 (9.2-16.8) | 12.8 (6.8-16) | 12.1 (10.1-15.1) | 10.9 (6.1-12.2) | 10.2 (7.1-14.7) | 9.7 (7.2-14.2) |
| PB WBC (×109/L) | 5.4 (1.8-13.1) | 17.3 (3.4-249.9) | 22.8 (2.4-307.4) | 13 (.4-79.8) | 7.9 (.8-124) | 6.6 (.7-64.9) |
| PB Plts | 171 (20-527) | 118 (21-232) | 252 (39-1430) | 36 (5-230) | 41.4 (11-203) | 44.5 (1-413) |
| PB Nt (% of WBC) | 62 (24-76) | 18 (0-73) | 58 (20-85) | 8 (0-89) | 6 (0-76) | 34.5 (3.74) |
| PB Ly (% of WBC) | 21 (14-72) | 71 (10-97) | 10.5 (1.36) | 12 (0-66) | 28 (2-93) | 30.5 (2-90) |
| BM cellularity (%) | 20 (10-50) | 50 (15-95) | 90 (20-100) | 85 (10-95) | 80 (15-100) | 63 (15-100) |
| BM blasts (%) | 1 (0-4) | 0 (0-0) | 2 (0-47) | 92 (79-99) | 70 (1-99) | 8.5 (2-29) |
| BM progranulocytes (%) | 2 (1-4) | 0 (0-2) | 2 (0-12) | 0 (0-4) | 1 (0-90) | 2 (0-10) |
| BM granulocytes (%) | 19 (12-31) | 5 (0-22) | 23 (10-63) | 0 (0-7) | 1.5 (0-29) | 14.5 (0-41) |
| BM Ly (%) | 13 (4-26) | 76 (7-93) | 4 (0-14) | 1 (0-7) | 5.5 (0-51) | 8 (2.57) |
| BM basophils (%) | 0 (0-2) | 0 (0-1) | 1 (0-11) | 0 (0-0) | 0 (0-1) | 0 (0-7) |
| BM prolymph (%) | 0 (0-0) | 1 (0-48) | 0 (0-0) | 0 (0-0) | 0 (0-0) | 0 (0-0) |
BM indicates bone marrow; Hb, hemoglobin; Ly, lymphocytes; Nt, neutrophils; PB, peripheral blood; Plts, platelets; Prolymph, prolymphocytes; WBC, white blood cells.